- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$50.54 MnMarket Estimate, 2026
$53.83 MnMarket Forecast, 2034
$89.09 MnCAGR, 2026–2034
6.5%Executive Summary: APAC Organ Preservation Market
- Market Scope: Regional evaluation of the Asia-Pacific organ preservation sector, detailing preservation solutions, transportation techniques, organ types, technological advancements (AI and robotics), and country-level profiles.
- Market Valuation: Valued at USD 50.54 million in 2025, reaching USD 53.83 million in 2026, and projected to expand to USD 89.09 million by 2034, growing at a robust CAGR of 6.50% from 2026 to 2034.
- Primary Growth Drivers: Rising incidence of organ failures driven by severe diabetes and chronic diseases, increasing organ transplantation success rates, government programs promoting organ donation, and technological advancements like AI and robotics.
Key Market Segment Metrics
| Category | Leading Segment (Base Position) | Fastest-Growing / High-Growth Segment |
|---|---|---|
| By Preservation Solution | UW (University of Wisconsin) Solution (dominated in 2025, driven by its clinical reputation and widespread adoption in multi-organ preservation) | Custodiol HTK (anticipated at a high-growth rate, propelled by single-dose microvascular protection and extended flush efficiency) |
| By Transportation Technique | Static Cold Storage (held major market share, anchored by standard transplant center practices and cost-effective logistics) | Hypothermic Machine Perfusion (expected to register strong growth due to better organ viability assessment and extended preservation windows) |
| By Organ Type | Kidneys (captured the major market share, supported by high volumes of renal failure cases and successful transplant records) | Liver (projected at an accelerated CAGR, driven by rising end-stage liver diseases and advanced surgical capabilities) |
| By Country | China & Japan (regional market leaders supported by advanced transplant facilities, growing geriatric populations, and favorable reimbursement policies) | India & South Korea (key high-growth hubs propelled by rising healthcare spending, expanding medical tourism, and increasing organ donation awareness) |
Major Market Players & Industry Landscape
Market Structure: Specialized medical technology environment featuring established global organ recovery and perfusion solution providers supplying specialized preservation fluids and devices to regional medical centers.
Key Companies: Essential Pharmaceuticals, Dr. Franz Kohler Chemie GmbH, Organ Recovery Systems, Xvivo Perfusion AB, and Waters Medical Systems LLC.
Download Free Sample Report
APAC Organ Preservation Market Size
The APAC Organ Preservation Market is projected to grow from USD 50.54 million in 2025 to USD 53.83 million in 2026 and reach USD 89.09 million by 2034, registering a CAGR of 6.50% from 2026 to 2034.
DRIVERS
The number of cases of organ failure caused by various health conditions, such as severe diabetes, is increasing rapidly around the world. This has resulted in a sharp increase in the number of organ transplants. As a result, the demand for organ preservation has also increased worldwide. Despite a large gap between organ supply and demand, there are many programs being implemented to promote organ donation in order to meet the growing demand for organ transplants, which will likely contribute to the growth of the APAC organ preservation market during the forecast period.
Due to various advancements in the field of organ transplantation and preservation, the APAC organ preservation market is estimated to grow during the forecast period with a healthy CAGR. Advances in conservation technologies and techniques have also increased the accessibility of organs in remote areas. In addition, with the technological advances in the medical field, the success rates of organ transplants are increasing, so that more and more people are opting for such a transplant.
RESTRAINTS
Organ transplant surgery is one of the most expensive in the healthcare. This is because the number of donations is far less than the demand for organ transplants, which creates a huge demand and supply gap. Due to this gap, obtaining an organ is a difficult task, which results in a hike in the prices of organs in black market sales. The sharp decline in organ donations also exacerbates the dearth of transplantable organs and the need for organ transplants. Furthermore, transplant surgeries are very expensive, which is a major hindrance to the growth of the organ preservation market.
OPPORTUNITIES
Technological advancements such as use of Artificial intelligence and robots are providing better opportunities for the market growth.
CHALLENGES
The Covid-19 pandemic has had a significant detrimental impact on the APAC organ preservation market. As the number of Covid-19 cases have increased, all non-essential and elective surgical procedures are immediately postponed. As a result, the need for organ preservation has reduced. These surgeries also involves the utilization of ICUs and medical ventilators, which were prioritized for use for Covid-19 critical treatment cases. Furthermore, allowing organ transplant procedures in the presence of highly communicable virus is not advised. Therefore, the most surgeries were postponed, this resulted in the decrease in the demand for organ preservation.
This research report on the Asia Pacific Organ Preservation Market has been segmented and sub-segmented into the following categories:
By Preservation Solution:
- UW
- Custodiol HTK
- Perfadex
By Transportation Technique:
- Static Cold Storage
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
By Organ Type:
- Kidneys
- Liver
- Lung
By Country:
- India
- China
- Japan
- South Korea
- Australia
- New Zealand
- Thailand
- Malaysia
- Vietnam
- Philippines
- Indonesia
- Singapore
- Rest of APAC
REGIONAL ANALYSIS
The fastest growth in APAC market is attributed to the rising population, improved the standard of living, increasing healthcare spending and demand for new and innovative treatment options.
China has an increasing geriatric population with organ failure cases, favorable reimbursement policies, and increasing burden of diabetes, cardiovascular disorder, diabetic nephropathy, and obesity would positively impact market growth in the coming years.
Japan is highly advanced in the practice of organ preservation. Thus, it holds the considerable share in the APAC organ preservation market. For instance, by the end of 2016, there were 32 facilities, performing transplants, which successful track record of kidney transplantation. Pacific regions will also have healthy growth rate due to awareness and advanced healthcare facilities in upcoming years.
KEY MARKET PLAYERS:
Some notable companies operating in the Asia Pacific Organ Preservation Market profiled in the report are Essential Pharmaceuticals, Dr. Franz Kohler Chemie GmbH, Organ Recovery Systems, Xvivo Perfusion AB, and Waters Medical Systems LLC.